Primitive neuroectodermal tumors (PNETs) are one of the most frequent types of 'non-germ cell' tumor in patients with testicular germ cell tumors and have a guarded prognosis when present in metastatic sites after cisplatin-based chemotherapy. Improved treatments, including targeted therapy, require understanding the biology of these neoplasms. We therefore analyzed the morphologic, immunohistochemical and molecular biologic features of 14 PNETs from 14 patients with concurrent or previous testicular germ cell tumors; 12 tumors were from metastatic sites and 2 were primary in the testis. Using standard light microscopic criteria for central nervous system and peripheral PNETs, we classified nine tumors as medulloepithelioma, three as medulloblastoma/supratentorial PNET, one as neuroblastic tumor with abundant neuropil and true rosettes and one as small cell embryonal tumor/PNET (Ewing sarcoma-like). Immunostains directed against INI1, CD57, S-100 protein, NeuN, WT1, neurofilament, CD99, GFAP, synaptophysin, chromogranin, AE1/AE3 cytokeratin, Fli-1 and collagen IV were performed for each case. INI1 was diffusely and strongly positive in all tumors whereas the other stains, except for cytoplasmic WT1 (which showed substantial reactivity in most tumors), were mostly focal to negative, including CD99 (eight negative, six focal) and Fli-1 (all negative). The most consistently reactive 'neuroendocrine' marker was CD57. Each case was also analyzed for chromosome 22 rearrangements using a FISH-based break-apart probe method. Only 1 tumor, classified as medulloepithelioma, was scored positive for chromosome 22 translocation (22% rearranged cells) and the remaining 13 were negative, including the one case that resembled peripheral PNET. We conclude that PNETs derived from testicular germ cell tumors mostly resemble central nervous system PNETs and generally lack the chromosome 22 translocation of peripheral PNETs. Future treatment strategies should take these findings into account.
The development of a metastatic primitive neuroectodermal tumor (PNET) in a patient with a testicular germ cell tumor carries a guarded prognosis. Ganjoo et al 1 reported that only 44% of patients who presented with metastases were disease free at a median follow-up of 19 months. Although newer chemotherapy protocols show potential for improving this outcome, there remains a need for more effective treatment. 2 Targeted modalities have proved efficacious in a number of tumor types, either with specific genetic changes that activate certain cellular signaling pathways or that lack mutations capable of bypassing an inhibitory effect. Thus, imatinib mesylate is useful in the treatment of gastrointestinal stromal tumors with specific activating mutations in the KIT gene; 3 trastuzumab frequently induces clinical responses in breast carcinomas with ERBB2 amplification, 4 and cetuximab is only effective in colorectal carcinomas with wild-type KRAS. 5 Although targeted therapy is not yet available for germ cell tumor-derived PNETs, it makes sense to analyze the nature of these neoplasms from their histomorphological, immunohistochemical and genetic aspects in anticipation of the application of targeted therapy at some future time. This is particularly the case with PNET, because the term 'PNET' is applied to several tumor types, notably a family of central nervous system neoplasms that occur mostly in children and which have an embryonal-type morphology (central PNET), [6] [7] [8] as well as to a more homogenous entity-Ewing sarcoma/PNET-that is caused by a specific chromosomal translocation (t (11;22) ) (peripheral PNET). 9, 10 The former entity includes neoplasms such as medulloblastoma, supratentorial PNET, medulloepithelioma and others. We therefore report the results of a light microscopic, immunohistochemical and molecular biologic investigation of 14 PNETs from patients with testicular germ cell tumors.
Materials and methods
This study was approved by the Institutional Review Board of Indiana University Purdue University at Indianapolis. A computerized text search of surgical pathology reports at Indiana University Hospital was performed for the phrase 'primitive neuroectodermal. ' The reports were reviewed to determine if the diagnosis represented PNETs, if the patient was a testicular germ cell tumor patient, and if the case was 'in house' with available paraffin blocks of tumor. In this way, 12 metastatic PNETs (10 retroperitoneal, 1 liver and 1 kidney) from 12 testicular germ cell tumor patients were identified. In addition, two primary testicular PNETs that were associated with other germ cell tumor types were identified in two separate patients. None of the cases were included in a previous study of germ cell tumor-related PNETs from our institution. 11 The hematoxylin and eosin slides of these cases were reviewed to allow selection of appropriate blocks for immunohistochemical and molecular studies.
For immunohistochemical studies, four micron, formalin-fixed, paraffin-embedded tissue sections were picked-up and dried on positively charged slides (Superfrost Plus, Erie Scientific, Portsmouth, NH, USA), deparaffinized in xylene and rehydrated through graded alcohols to distilled water. The antibody sources, dilutions and antigen retrieval methodologies are shown in Table 1 . The detection method varied by antibody. For AE1/AE3 anticytokeratin and antibodies directed against synaptophysin, chromogranin, S-100 protein, NeuN, collagen IV, laminin, CD99, CD57 and Fli-1, a peroxidaseconjugated streptavidin methodology (Labeled Streptavidin-Biotin (LSAB) 2 system, Dako, Carpinteria, CA, USA) with either biotinylated goat anti-rabbit or biotinylated goat anti-mouse secondary antibodies (Dako) was used. For antibodies directed against INI1 and WT1 proteins, the LSAB þ (Dako) method was used. For GFAP, a polymer-based method (Ultra Vision One, Lab Vision, Freemont, CA, USA) was used.
The immunohistochemical stains were evaluated on the basis of the extent and intensity of the colorimetric reaction. For extent, 0 ¼ negative staining; 1 ¼ r10%; 2 ¼ 410-50%; 3 ¼ 450%. For intensity, 1 ¼ faint; 2 ¼ moderate; 3 ¼ strong. Each stain was 'scored' based on extent and intensity by multiplying the two values to achieve results from 0 to 9.
For fluorescence in situ hybridization, tissue sections 4 mm in thickness were prepared from buffered, formalin-fixed, paraffin-embedded tissue blocks containing tumor. The slides were deparaffinized with two washes of xylene, 15 min each, and In all, 5 ml of diluted probe was applied to each slide in reduced light conditions. The slides were then covered with a 22 Â 22 mm cover slip and sealed with rubber cement. Denaturation was achieved by incubating the slides at 83 1C for 12 min in a humidified box and hybridization at 37 1C overnight. The cover slips were removed and the slides were washed twice with 0.1XSSC/1.5 M urea at 45 1C (20 min for each), followed by a wash with 2 Â SSC for 20 min and with 2 Â SSC/0.1% NP-40 for 10 min at 45 1C. The slides were further washed with room temperature 2 Â SSC for 5 min. The slides were air dried and counterstained with 10 ml DAPI (Insitus), covered with coverslips and sealed with nail polish. The slides were examined using a Zeiss Axioplan 2 microscope (Zeiss, Gottingen, Germany) with the following filters from Chroma (Chroma, Brattleboro, VT, USA): SP-100 DAPI, FITC MF-101 for Spectrum Green and Gold 31003 for Spectrum Orange. The images were acquired with a CCD camera and analyzed with MetaSystem Isis Software (MetaSystem, Belmont, MA, USA). Five sequential focus stacks with 0.4 mm intervals were acquired and then integrated into a single image to reduce thickness-related artifacts. As a positive control, a case of Ewing sarcoma/PNET with a known positive translocation, (t(11;22)), as determined by classic cytogenetic analysis, was run in parallel with the study cases. The method for in situ hybridization analysis with the Vysis break-apart probe has been previously reported. [12] [13] [14] [15] [16] [17] Briefly, 100 nuclei from a tumor area were counted for probe signals under a fluorescence microscope at Â 1000 magnification. Only nonoverlapping tumor nuclei with two red and two green signals were counted. Cells with fused green and red signals or close adjacent green and red signals were considered normal. The cells with one fused signal and separated green and red signals, when the distance between green and red signals was greater than twofold the signal diameter, were considered positive for breakapart. A cut-off value of 20% of nuclei showing a split signal was considered a positive result for gene rearrangement, as has been previously used. 12, 14, 15 The in situ hybridization and analysis were performed twice on each the 14 samples at two different times and using different sample identifiers to verify the results.
Results

Clinical Findings
The 14 patients ranged from 19 to 43 years of age (median 30.5 years) at the time of surgical resection of the specimen containing the PNET. The PNET was located in the retroperitoneum in 10 cases, the testis in 2, and the liver and kidney (1 each). Eleven patients had established non-seminomatous testicular germ cell tumors based on review of the orchiectomy specimens at our institution. Teratoma was found in each of these 11 testicular specimens, yolk sac tumor in 7, embryonal carcinoma in 5 and seminoma and choriocarcinoma in 1 each. In addition, in nine of these cases, PNET was identified in the testicular specimens based on the criterion of overgrowth of primitive neuroectodermal tissue to the extent that the majority of a low power (4X objective) field was occupied, as has been previously described for the distinction of PNET from 'immature teratoma.' 18 In one case, no review of the testicular primary had been performed but the diagnosis of a non-seminomatous germ cell tumor was supported by an elevated serum alpha-fetoprotein level at the time of orchiectomy. In addition, one patient, a 43-year-old man ( Table 2 , case 4), had a pure testicular PNET that had overgrown the testis to the extent that residual seminiferous tubules had been totally replaced, therefore not allowing recognition of intratubular germ cell neoplasia. The final patient had a history of testicular germ cell tumor but no specific information was available regarding the precise elements of his tumor. Nine patients received cisplatin-based chemotherapy before resection of the PNET-bearing specimen and five did not (including the two patients whose testicular primaries were analyzed).
Pathologic Findings
On gross examination the regions corresponding to PNET consisted of fleshy, solid, gray-white tissue. On microscopic examination, the tumors showed varying proportions of several patterns. Primitive, often anastomosing neural tubules were present in nine cases; these consisted of stratified columnar tumor cells arranged in a radial manner around an open central luminal space, with the peripheral aspect of the tubules distinctly set apart by an apparent basement membrane (Figure 1a) . A primitive-appearing oval to spindle cell component partially occupied the intertubular spaces in six of these cases (Figure 1a) . Mitotic figures were easily found in the tubules, including along the luminal border. Ganglion cells were identified in the stroma of two and glial cells in one. In accordance with criteria for central nervous system tumors, 8 such cases were classified as medulloepitheliomas ( Table 2 ). The case of the pure testicular PNET ( Table 2 , case 4) lacking recognizable germ cell tumor elements of the usual type was among these nine medulloepitheliomas.
Three tumors were classified as medulloblastoma/ supratentorial PNET. The tumor cells were arranged in sheets. Two had cells with scant, ill-defined, pale cytoplasm and indistinct cytoplasmic membranes. In one of these cases, the cells were round and focally associated with a vague, neuropil-like stroma (Figure 1b) . In the second of these two tumors, the cells had oval to spindled profiles and formed ill-defined fascicles (Figure 1c ). The third example had closely packed but discohesive, polygonal cells with a moderate amount of eosinophilic cytoplasm, prominent nucleoli and frequent mitotic figures and apoptotic bodies (Figure 1d) . Distinct rosettes or pseudorosettes were not identified in any of these cases.
One tumor was classified as a neuroblastic tumor with abundant neuropil and true rosettes. 19 It consisted of primitive-appearing, small to mediumsized cells arranged in clusters in an eosinophilic, fibrillar matrix with occasional true rosettes (Figure 1e) .
One final tumor consisted of multiple discrete nests of uniform, round tumor cells in a loose, fibrous stroma (Figure 1f ). Mitotic figures were sparse. This case was classified as a small cell embryonal neoplasm, not otherwise specified and was felt to have features reminiscent of peripheral PNET/Ewing sarcoma.
Five tumors showed glomeruloid vascular proliferation. These included two cases each of tumors classified as medulloepithelioma and medulloblastoma/supratentorial PNET and the case showing the features of a neuroblastic tumor with abundant neuropil and true rosettes.
Immunohistochemical Findings
The immunohistochemical staining results are summarized in Table 2 . All tumors stained strongly and diffusely for INI1. A majority of the other markers were patchy and/or weak. Cytoplasmic but not nuclear expression of WT1 occurred in all cases and tended to be more impressive in tumors classified as medulloepithelioma compared with others (Figure 2a) , although overall there was no strong correlation between the light microscopic classification and the immunohistochemical findings. Of the markers that are usually considered 'neuroendocrine,' CD57 was most frequently positive (Figure 2b) , followed by synaptophysin, NeuN (Figure 2c) and neurofilament (Figure 2d ). The latter three, however, were frequently negative. Chromogranin only marked two cases, both classified as medulloepithelioma. Focal to rare S-100 reactivity occurred in all but one case but was often weak. AE1/AE3 cytokeratin was most likely to be positive in neural tubules and therefore occurred most robustly in a minority of the cases classified as medulloepithelioma (Figure 2e ) ( Table 2) . Collagen IV highlighted the external basement membrane that separated tubular structures from the surrounding stroma in five cases of medulloepithelioma (Figure 2f ). GFAP positivity was observed in only two cases, both medulloepitheliomas. The two markers associated with Ewing sarcoma/peripheral PNET, CD99 and Fli-1, were infrequently reactive (CD99), never strongly and diffusely so, or uniformly negative (Fli-1).
Fluorescence In Situ Hybridization Findings
Using the chromosome 22 break-apart probe, one case ( medulloepithelioma. The immunohistochemical staining pattern of this case (Table 2) overlapped with those of the other tumors. The percentage of cells with positive hybridization signals in the remaining 13 cases fell below this cut-off value, ranging from 0 to 14% (Table 2) .
Discussion
It has been clear, for over a decade, that PNETs represent one of the more frequent forms of 'nongerm cell' tumor that develop in patients with testicular germ cell tumors and that they have a poor prognosis when found in metastatic sites after primary or secondary chemotherapy. 1, 11 A majority of such PNETs show morphologic features of those primitive tumors of the central nervous system that are characteristically observed in children, 11 especially in the posterior fossa, and this is also true for the PNETs that develop in the ovary. 20 There remains, however, relatively scant information regarding the morphologic spectrum of these PNETs. 10 These considerations prompted this study.
Our study verified a disproportionate frequency of tumors with the morphologic features of 'medulloepithelioma,' which contrasts with the uncommonness of this neoplasm among central nervous system PNETs. 8 These tumors formed large tubular structures, often with an investing basement membrane as shown by collagen IV immunostains, that set the tubules apart from the adjacent stroma. Additional morphologies that are typically encountered in central nervous system neoplasms of children were also found, including neuroblastic tumor with abundant neuropil and true rosettes 19, 21 and medulloblastoma/supratentorial PNET. 8 One tumor, classified as a small cell embryonal tumor/ PNET, had features that could be observed in either a peripheral PNET/Ewing sarcoma or an undifferentiated embryonal tumor of the central nervous system. We found no evidence for any relationship of our cases to the atypical teratoid/rhabdoid tumor 22, 23 that is mostly observed in the central nervous system of young children in that no distinct rhabdoid morphology was appreciated and there was uniform retention of immunoreactivity for INI1 protein. Our experience was therefore similar to that of Michael et al 11 in a similar cohort of testicular germ cell tumor patients. These investigators reported a predominance of testicular PNETs having the morphologic features of medulloepitheliomas, although in that series the metastatic lesions classified as PNETs more commonly resembled neuroblastomas or peripheral PNETs. The same holds true for ovarian PNETs. In the series of Kleinman et al, 20 which included 12 cases of PNETs of the ovary among a collection of 25 primary ovarian neuroectodermal tumors, 4 were classified as medulloepitheliomas, 3 as neuroblastomas, 3 as ependymoblastomas and 2 as medulloblastomas.
It is therefore evident that the majority of gonadalderived PNETs do not resemble peripheral PNET/ Ewing sarcoma, but there are some morphologically ambiguous cases. One of the tumors in our series showed a nested arrangement of uniform, small cells in a fibrous stroma in which peripheral PNET/ Ewing sarcoma was a serious diagnostic consideration (case 14, Table 2 ) (Figure 1f ). In the study of Michael et al, 11 a number of the metastatic tumors of testicular origin were classified as 'peripheral neuroepithelioma' based on their light microscopic appearance and CD99 reactivity, a finding contrasting with this study wherein strong and diffuse CD99 was not encountered, and those tumors that showed some degree of CD99 reactivity did not have morphological features of peripheral PNET/Ewing sarcoma. Nonetheless, these two studies illustrate that peripheral PNET/Ewing sarcoma remains a significant diagnostic consideration for some of the PNETs that occur in testicular germ cell tumor patients.
Our results provide little support that any of the PNETs we encountered in testicular germ cell tumor patients were of the peripheral PNET/Ewing sarcoma type. In a study of 43 cases of PNET/Ewing sarcoma, the combination of immunopositivity for both CD99 and polyclonal Fli-1 (the same antibody used in our study) was considered the best method for confirming the diagnosis, as assessed by analysis of areas under receiver operator curves looking at possible combinations of three markers (monoclonal antibody to Fli-1, polyclonal antibody to Fli-1 and antibody to CD99).
14 This method had a sensitivity of detection of 93%. In contrast, none of our cases showed positivity for both of these markers and only two had more than 10% immunoreactivity for CD99, both medulloepitheliomas. One of our cases showed a positive chromosome 22 rearrangement as assessed by a FISH-based break-apart probe assay. In this case, 22% of the evaluated tumor cells were scored as positive for a separated signal, which was just slightly above our cut-off value of 20%. In other studies, however, of known PNET/Ewing sarcoma that used this same method, the proportion of positive cells was significantly higher. Thus, Bridge et al 16 reported a mean of 79% positivity (range, 36-96%); Yamaguchi et al 17 found 50-90% positivity; and, using a cut-off value of 30%, all 10 cases of superficial PNET/Ewing sarcoma with interpretable results reported by Terrier-Lacombe et al 13 were positive. It is therefore questionable if our single case should be considered a true positive, given the low proportion of tumor cells showing separated probe signals, noting that it would not have been considered positive using the more stringent cutoff of one study. 13 On the basis of the absence of CD99 and Fli-1 immunoreactivity and its light microscopic appearance, this tumor ( Table 2 , case 8) is not a peripheral PNET/Ewing sarcoma but a medulloepithelioma-like tumor.
Although most metastatic PNETs in germ cell tumor patients have a distinctive morphology, occasional cases with a diffuse pattern and lacking defined tubules and rosettes raise differential diagnostic considerations that may be observed in the same context. The distinction of central from peripheral PNETs has been the focus of our study, but both nephroblastoma and embryonal rhabdomyosarcoma also merit consideration. In our opinion, nephroblastoma is the most problematic consideration, given its frequent tubular morphology and blastematous component. The tubules in nephroblastoma, however, are typically smaller and are lined by cuboidal, less stratified cells that those in germ cell tumor-related PNETs, which are frequently lined by several layers of columnar cells. The presence of glomeruloid structures and the absence of rosettes and a neurofibrillary-type matrix are also helpful in the recognition of nephroblastoma. Furthermore, nuclear reactivity for WT1 protein occurs in 59-73% of nephroblastomas 24, 25 but is absent in germ cell tumor-derived PNETs.
Embryonal rhabdomyosarcoma is the most common secondary malignancy in testicular germ cell tumors 26, 27 and may be confused with diffuse PNETs. Occasional distinct rhabdomyoblasts with eosinophilic cytoplasm are helpful in the distinction from PNET, and cross striations are pathognomonic. The complete absence in embryonal rhabdomyosarcoma of tubular structures and rosettes is helpful. Appropriate muscle markers (desmin, myogenin) easily permit the distinction of these two entities.
As advances are made in targeted therapy, it is important to understand the molecular basis of neoplasms. Nomenclature can be confusing, both to pathologists and treating physicians. Our study verifies that the tumors that are observed in patients with testicular germ cell tumors and that are commonly classified as PNETs have morphological features akin to pediatric central nervous system tumors of embryonic type. Even those tumors that may show some light microscopic resemblance to peripheral PNET/Ewing sarcoma are, we feel, unlikely to be true peripheral PNETs based on our experience, although appropriate immunohistochemical or molecular evaluation is required. Caution is also urged regarding the interpretation, or better stated, the over-interpretation, of FISH breakapart probe results. In spite of no morphological or immunohistochemical support, one of our cases had a positive FISH assay (verified in duplicate) for chromosome 22 rearrangements at a relatively low cut-off value. We consider this a false-positive result. Therefore, molecular biologic data, while extremely valuable in the understanding and classification of neoplasms, must be interpreted in the context of traditional morphology and immunohistochemistry.
